Helen Torley

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Diego, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ James R. Oehler, Attorney-in-Fact
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Helen Torley

Form 4 holding PRESIDENT AND CEO, Director

HALOZYME THERAPEUTICS, INC.

Security class
Restricted Stock Units
Shares / value
44,872
Estimated value
$3,923,383
Report date
23 Feb 2026
Price
$58.29
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding PRESIDENT AND CEO, Director

HALOZYME THERAPEUTICS, INC.

Security class
Option to Purchase Common Stock
Shares / value
1,923
Estimated value
$2,437,210
Report date
03 Jun 2026
Price
$12.07
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

QUEST DIAGNOSTICS INC

Security class
Common Stock
Shares / value
6,260
Estimated value
$769,122
Report date
25 May 2021
Price
$122.86
Ownership
Direct

Insider Reports Filed by Helen Torley

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .